Alpha 2.0
Login Register
» Authors » J Y Huang

J Y Huang

Explore the profile of J Y Huang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 151
Citations 730
Followers 0
Related Specialties
Biophysics
General Medicine
General Surgery
Top 10 Co-Authors
C C Huang
M S Wu
K W Su
C H Wu
G Chen
Y F Chen
K F Huang
Z F Ren
S Chen
M S Dresselhaus
Published In
Phys Rev Lett
Appl Opt
Nano Lett
Opt Express
Changgeng Yi Xue Za Zhi
Affiliations
Soon will be listed here.
Recent Articles
1.
A singlet-triplet hole-spin qubit in MOS silicon
Liles S, Halverson D, Wang Z, Shamim A, Eggli R, Jin I, et al.
Nat Commun . 2024 Sep; 15(1):7690. PMID: 39227367
Holes in silicon quantum dots are promising for spin qubit applications due to the strong intrinsic spin-orbit coupling. The spin-orbit coupling produces complex hole-spin dynamics, providing opportunities to further optimise...
2.
[Unsupervised clustering analysis based on multidimensional features reveals distinct clinical characteristics and associated factors of different phenotypes in patients with chronic rhinosinusitis with nasal polyp]
Huang J, Luo Y, Lyu H, Liu D, Wang Y, Liu P, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi . 2024 Jul; 59(6):590-601. PMID: 38965849
To utilize routinely available clinical parameters to uncover the clinical features of different clusters in patients with chronic rhinosinusitis with nasal polyp (CRSwNP) through unsupervised clustering analysis. The clinical data...
3.
Effect of pneumatic leg compression on phenylephrine dose for hypotension prophylaxis via variable rate infusion at cesarean delivery: an unblinded randomized controlled trial
Yao H, Huang J, Dong Y, Sun X, Wang L
Int J Obstet Anesth . 2024 Jun; 60:104218. PMID: 38925990
Background: Phenylephrine infusion is recommended to prevent spinal hypotension during cesarean delivery (CD) but may be associated with dose-dependent side effects. We hypothesized that adding intermittent pneumatic compression (IPC) of...
4.
[Comparison of risk factors for hemorrhagic stroke and ischemic stroke, a prospective long-term follow-up cohort study]
Li X, Huang J, Guo J, Gu Z, Liu G, Zhang Y, et al.
Zhonghua Liu Xing Bing Xue Za Zhi . 2023 Sep; 44(9):1383-1389. PMID: 37743270
To analyze and compare the risk factors for hemorrhagic stroke and ischemic stroke and understand the exposure levels in population. A cohort study of risk factors of stroke was conducted...
5.
[Short-term efficacy and safety observation of standardized mite allergen extract rush subcutaneous immunotherapy for allergic rhinitis: a prospective study]
Huang J, Zhang W, Xiang R, Deng Y, Tao Z, Xu Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi . 2023 Sep; 58(9):854-862. PMID: 37675523
To conduct a comparative analysis of the efficacy, safety, and cytokine changes associated with three distinct dose escalation regimens of allergen-specific immunotherapy (AIT), and to provide valuable insights into the...
6.
[Endovascular therapy accompanied by spontaneous portosystemic shunts for overt hepatic encephalopathy]
Zhao T, Huang J, Liu C, Chen R, Fan W, Zheng W
Zhonghua Gan Zang Bing Za Zhi . 2023 May; 31(2):181-185. PMID: 37137834
To preliminarily evaluate the safety and efficacy of shunt-related interventional therapy accompanied with spontaneous portosystemic shunts (SPSS) in patients with hepatic encephalopathy (HE). Case data on six patients who underwent...
7.
Prospective associations of circulating thrombospondin-2 level with heart failure hospitalization, left ventricular remodeling and diastolic function in type 2 diabetes
Lee C, Wu M, Lui D, Fong C, Ren Q, Yu S, et al.
Cardiovasc Diabetol . 2022 Nov; 21(1):231. PMID: 36335340
Background: Circulating thrombospondin-2 (TSP2) levels were associated with the development of heart failure (HF) in recent studies. However, these studies included only a minority of patients with type 2 diabetes,...
8.
[Atezolizumab therapy in Chinese patients with locally advanced or metastatic solid tumors: An open-label, phase Ⅰ study]
Zhang L, Gong J, Pan H, Bai Y, Liu T, Cheng Y, et al.
Beijing Da Xue Xue Bao Yi Xue Ban . 2022 Oct; 54(5):971-980. PMID: 36241241
Objective: To evaluate pharmacokinetics (PK), efficacy, and safety of atezolizumab (anti-PD-L1) in high interest cancers in China, including esophageal cancer (EC), gastric cancer (GC), hepatocellular carcinoma (HCC), nasopharyngeal cancer (NPC),...
9.
[Evaluation of the effectiveness of malaria control health education among overseas enterprise employees]
Du Y, Liang C, Gu Y, Zhou H, Huang J, Cao J
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi . 2022 Sep; 34(4):383-391. PMID: 36116928
Objective: To evaluate the effectiveness of health education on knowledge, attitude and practice (KAP) relating to malaria control among overseas enterprise employees. Methods: In September 2019, on-site malaria control health...
10.
[Screening and preliminary validation of biomarkers in sputum-negative pulmonary tuberculosis based on positron emission tomography/computed tomography and transcriptomics]
Wu L, Wang L, Wen Z, Ma H, Ou Q, Wu C, et al.
Zhonghua Jie He He Hu Xi Za Zhi . 2022 Jun; 45(6):567-572. PMID: 35658381
To screen and perform preliminary clinical validation of biomarkers of activity based on positron emission tomography/computed tomography (PET-CT) and transcriptomics in sputum-negative pulmonary tuberculosis lesion tissue. Nine patients with sputum-negative...